Outcomes among adult recipients of CD19 CAR T-cell therapy for Burkitt lymphoma

被引:0
|
作者
Samples, Laura S.
Sadrzadeh, Hossein
Frigault, Matthew J.
Jacobson, Caron Alyce
Hamadani, Mehdi
Gurumurthi, Ashwath
Strati, Paolo
Shouval, Roni
Riedell, Peter A.
Dahiya, Saurabh
Yared, Jean
Jain, Michael D.
Locke, Frederick L.
Leslie, Lori Ann
Epperla, Narendranath
Ghosh, Monalisa
Skarbnik, Alan
Hill, Brian T.
Kamdar, Manali K.
Shadman, Mazyar
机构
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA USA
[2] Boston Univ, Med Ctr, Boston, MA USA
[3] Massachusetts Gen Hosp, Boston, MA USA
[4] Dana Farber Canc Inst, Boston, MA USA
[5] Med Coll Wisconsin, Milwaukee, WI USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX USA
[7] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[8] Mem Sloan Kettering Canc Ctr, New York, NY USA
[9] Univ Chicago, Med Ctr, Chicago, IL USA
[10] Stanford Canc Ctr GI Surg Oncol, Stanford, CA USA
[11] Univ Maryland, Baltimore, MD USA
[12] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[13] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[14] John Theurer Canc Ctr, Hackensack, NJ USA
[15] Ohio State Univ, Columbus, OH USA
[16] Univ Michigan, Hlth Management Res Ctr, Ann Arbor, MI USA
[17] Novant Hlth Canc Inst, Charlotte, NC USA
[18] Cleveland Clin, Cleveland, OH USA
[19] Univ Colorado Hosp, Aurora, CO USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7571
引用
收藏
页数:1
相关论文
共 50 条
  • [11] CAR19/22 T cell therapy in adult refractory Burkitt's lymphoma
    Zhou, Xiaoxi
    Ge, Tong
    Li, Tongjuan
    Huang, Liang
    Cao, Yang
    Xiao, Yi
    Zhen, Miao
    Chen, Liting
    Zhou, Jianfeng
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (08) : 2379 - 2384
  • [12] A second CD19 CAR T-cell infusion: yes or no?
    Casucci, Monica
    Ciceri, Fabio
    BLOOD, 2021, 137 (03) : 284 - 286
  • [13] Anti-HLA antibodies in recipients of CD19 versus BCMA-targeted CAR T-cell therapy
    Hill, Joshua A.
    Kiem, Erika S.
    Bhatti, Atif
    Liu, Winnie
    Keane-Candib, Jacob
    Fitzpatrick, Kristin S.
    Boonyaratanakornkit, Jim
    Gardner, Rebecca A.
    Green, Damian J.
    Maloney, David G.
    Turtle, Cameron J.
    Smith, Jodi M.
    Gimferrer, Idoia
    Blosser, Christopher D.
    Jackson, Shaun W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (03) : 416 - 422
  • [14] Body Composition and Immunonutritional Status Impact Survival Outcomes after CD19 CAR T-Cell Therapy
    Rejeski, Kai
    dos Santos, David M. Cordas
    Trinkner, Paul
    Guenther, Sophie
    Liu, Lian
    Winkelmann, Michael
    Buecklein, Veit L.
    Blumenberg, Viktoria
    Schmidt, Christian
    Karschnia, Philipp
    Kunz, Wolfgang G.
    von Bergwelt, Michael
    Theurich, Sebastian
    Subklewe, Marion
    BLOOD, 2022, 140 : 10405 - 10406
  • [15] Disease Control Affects Outcomes of Patients with Relapsed Diffuse Large B Cell Lymphoma Treated with CD19 Directed CAR T-Cell Therapy
    Pan, Dorothy C.
    Hamid, Showkat
    Herr, Megan
    Attwood, Kristopher
    McCarthy, Philip L.
    Ross, Maureen
    Schofield, Grant
    Cortese, Matthew J.
    Lamonica, Dominick
    Wong, Jerry Thwin
    Fu, Kai
    Maslak, Peter
    Davila, Marco
    Brentjens, Renier
    Hernandez-Ilizaliturri, Francisco J.
    BLOOD, 2023, 142
  • [16] REFRACTORY PTLD WITH DLBCL PHENOTYPE TREATED WITH CD19 CAR T-CELL THERAPY
    Whitman, Abbie
    Damodharan, Sudarshawn
    Capitini, Christian
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S73 - S74
  • [17] Clinical features of neurotoxicity after CD19 CAR T-cell therapy in mantle cell
    Nie, Esther H.
    Su, Yi-Jiun
    Baird, John H.
    Agarwal, Neha
    Bharadwaj, Sushma
    Weng, Wen-Kai
    Smith, Melody
    Dahiya, Saurabh
    Han, May H.
    Dunn, Jeffrey E.
    Kipp, Lucas B.
    Miklos, David B.
    Scott, Brian J.
    Frank, Matthew J.
    BLOOD ADVANCES, 2024, 8 (06) : 1474 - 1486
  • [18] Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significant
    Chen, George
    Herr, Megan
    Nowak, Jan
    Ho, Christine
    Almyroudis, Nikolaos
    Attwood, Kristopher
    Bonnewell, John
    Walsh, Marissa
    Segal, Brahm
    Ross, Maureen
    McCarthy, Philip
    Hahn, Theresa
    HAEMATOLOGICA, 2023, 108 (02) : 615 - 620
  • [19] Infectious complications among CD19 CAR-T cell therapy recipients: A single-center experience
    Walker, Bryan
    Zimmer, Andrea J.
    Stohs, Erica J.
    Lunning, Matthew
    Lyden, Elizabeth
    Abbas, Anum
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25
  • [20] Infectious complications among CD19 CAR-T cell therapy recipients: A single-center experience
    Walker, Bryan
    Zimmer, Andrea J.
    Stohs, Erica J.
    Lunning, Matthew
    Lyden, Elizabeth
    Abbas, Anum
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25